| 发明名称 |
1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro- 4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo [4,5-b]pyridin-7-yloxy)-phenyl] -urea and related compounds and their use in therapy |
| 摘要 |
<p>The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain compounds of the following formula (I) (for convenience, collectively referred to herein as "IP compounds"), which,</p> |
| 申请公布号 |
AU2011209586(B2) |
申请公布日期 |
2016.01.21 |
| 申请号 |
AU20110209586 |
申请日期 |
2011.01.27 |
| 申请人 |
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE);CANCER RESEARCH TECHNOLOGY LIMITED |
发明人 |
SPRINGER, CAROLINE;NICULESCU-DUVAZ, ION;MARAIS, RICHARD;NICULESCU-DUVAZ, DAN;ZAMBON, ALFONSO;MENARD, DELPHINE |
| 分类号 |
C07D471/04;A61K31/437;A61P35/00 |
主分类号 |
C07D471/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
